6a57d64841594d5075e86a70-mp3

20:00 5 Sprekers 5 Hoofdstukken 477 segmenten

Hoofdstukken

  1. 0:02

    I just jump right in. The reason I'm bringing it up is like, you know, even in these meetings, which are like all informed people and in the guidelines and things, like it does, it impacts the community because like, you know, it's hard for…

  2. 5:02

    You know, HMOs and managed care really found its breadth within primary care, the breadth of general medical medicine diseases. Lo and behold, as you get older, cancer is part of it, and I don't think that philosophy has ever really transfe…

  3. 11:03

    Yeah. So there's two things to say to that. So one, I completely agree with you regarding the labeling. I think the labeling makes a big difference. Must, should, hospitalize, must, you know, there's like... It makes a big difference. You k…

  4. 16:08

    landscape are you thinking about Ticlistamab and Telquivab -based treatments? I'll open it up for discussion. Well, I mean, I think the major decision point is that are they CAR -T eligible or not? I think it's an important distinction in a…